Show
Sort by
-
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
-
Predicting recurrence and progression in stage TA T1 bladder cancer patients using EORTC risk tables
-
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies.
-
Treatment of superficial bladder tumors: achievements and needs
-
Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European organization for research and treatment of cancer randomized trials with Mitomycin C and Doxorubicin comparing early versus delayed instill ations and shor-term versus long-term treatment.
-
Factors affecting recurrence and progression in superficial bladder-tumours.
-
A PROSPECTIVE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GENITOURINARY GROUP RANDOMIZED TRIAL COMPARING TRANSURETHRAL RESECTION FOLLOWED BY A SINGLE INTRAVESICAL INSTILLATION OF EPIRUBICIN OR WATER IN SINGLE STAGE TA, T1 PAPILLARY CARCINOMA OF THE BLADDER.
-
A PLEA FOR COLD BIOPSY, FULGURATION AND IMMEDIATE BLADDER INSTILLATION WITH EPIRUBICIN IN SMALL SUPERFICIAL BLADDER-TUMORS - DATA FROM THE EORTC GU GROUP-STUDY 30863.
-
Prognostic factors in superficial bladder tumors
-
TUR only versus epirubicine in single primary or recurrent Ta Tl bladder tumors. EORTC Study 30.863